These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27895176)

  • 1. The Syk-NFAT-IL-2 Pathway in Dendritic Cells Is Required for Optimal Sterile Immunity Elicited by Alum Adjuvants.
    Khameneh HJ; Ho AW; Spreafico R; Derks H; Quek HQ; Mortellaro A
    J Immunol; 2017 Jan; 198(1):196-204. PubMed ID: 27895176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses.
    Mori A; Oleszycka E; Sharp FA; Coleman M; Ozasa Y; Singh M; O'Hagan DT; Tajber L; Corrigan OI; McNeela EA; Lavelle EC
    Eur J Immunol; 2012 Oct; 42(10):2709-19. PubMed ID: 22777876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of stress-mediated immunological functions with the adjuvanticity of alum.
    Wang Y; Rahman D; Lehner T
    J Biol Chem; 2012 May; 287(21):17152-17160. PubMed ID: 22474329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice.
    Bellinghausen I; Sudowe S; König B; Reske-Kunz AB; Knop J; Saloga J
    Int Arch Allergy Immunol; 2006; 141(1):61-9. PubMed ID: 16804328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses.
    Oleszycka E; McCluskey S; Sharp FA; Muñoz-Wolf N; Hams E; Gorman AL; Fallon PG; Lavelle EC
    Eur J Immunol; 2018 Apr; 48(4):705-715. PubMed ID: 29349774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells.
    McKee AS; Burchill MA; Munks MW; Jin L; Kappler JW; Friedman RS; Jacobelli J; Marrack P
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):E1122-31. PubMed ID: 23447566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity.
    Flach TL; Ng G; Hari A; Desrosiers MD; Zhang P; Ward SM; Seamone ME; Vilaysane A; Mucsi AD; Fong Y; Prenner E; Ling CC; Tschopp J; Muruve DA; Amrein MW; Shi Y
    Nat Med; 2011 Apr; 17(4):479-87. PubMed ID: 21399646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.
    Kool M; Soullié T; van Nimwegen M; Willart MA; Muskens F; Jung S; Hoogsteden HC; Hammad H; Lambrecht BN
    J Exp Med; 2008 Apr; 205(4):869-82. PubMed ID: 18362170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen depot is not required for alum adjuvanticity.
    Hutchison S; Benson RA; Gibson VB; Pollock AH; Garside P; Brewer JM
    FASEB J; 2012 Mar; 26(3):1272-9. PubMed ID: 22106367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine.
    Ko EJ; Lee YT; Kim KH; Lee Y; Jung YJ; Kim MC; Lee YN; Kang T; Kang SM
    J Immunol; 2017 Jan; 198(1):279-291. PubMed ID: 27881702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of CD300a Phosphatidylserine Immunoreceptor in Aluminum Salt Adjuvant-Induced Th2 Responses.
    Miki H; Nakahashi-Oda C; Sumida T; Shibuya A
    J Immunol; 2015 Jun; 194(11):5069-76. PubMed ID: 25911756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Jung YJ; Lee Y; Lee JS; Lee YN; Park S; Kang SM
    PLoS One; 2015; 10(10):e0139916. PubMed ID: 26468884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CR3 Engaged by PGL-I Triggers Syk-Calcineurin-NFATc to Rewire the Innate Immune Response in Leprosy.
    Doz-Deblauwe É; Carreras F; Arbues A; Remot A; Epardaud M; Malaga W; Mayau V; Prandi J; Astarie-Dequeker C; Guilhot C; Demangel C; Winter N
    Front Immunol; 2019; 10():2913. PubMed ID: 31921172
    [No Abstract]   [Full Text] [Related]  

  • 14. Contamination of DNase Preparations Confounds Analysis of the Role of DNA in Alum-Adjuvanted Vaccines.
    Noges LE; White J; Cambier JC; Kappler JW; Marrack P
    J Immunol; 2016 Aug; 197(4):1221-30. PubMed ID: 27357147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells.
    Kamath AT; Valenti MP; Rochat AF; Agger EM; Lingnau K; von Gabain A; Andersen P; Lambert PH; Siegrist CA
    Eur J Immunol; 2008 May; 38(5):1247-56. PubMed ID: 18412160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake.
    Liang F; Lindgren G; Sandgren KJ; Thompson EA; Francica JR; Seubert A; De Gregorio E; Barnett S; O'Hagan DT; Sullivan NJ; Koup RA; Seder RA; Loré K
    Sci Transl Med; 2017 Jun; 9(393):. PubMed ID: 28592561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
    Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
    J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination.
    Wang X; Cao F; Yan M; Liu Y; Zhu X; Sun H; Ma G
    Acta Biomater; 2019 Jan; 83():390-399. PubMed ID: 30448435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants.
    Sokolovska A; Hem SL; HogenEsch H
    Vaccine; 2007 Jun; 25(23):4575-85. PubMed ID: 17485153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro.
    Ghimire TR; Benson RA; Garside P; Brewer JM
    Immunol Lett; 2012 Sep; 147(1-2):55-62. PubMed ID: 22732235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.